Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report. by Gsell, P, Camacho, A, Kucharski, A, Watson, C, Bagayoko, A, Nadlaou, S, Dean, N, Diallo, A, Diallo, A, Honora, D, Doumbia, M, Enwere, G, Higgs, E, Mauget, T, Mory, D, Riveros, X, Oumar, F, Fallah, M, Toure, A, Vicari, A, Longini, I, Edmunds, W, Henao-Restrepo, A, Kieny, M, Kéïta, S

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’e... by Watson, CH, Gsell, P, Hall, Y, Camacho, A, Riveros, X, Enwere, G, Vicari, A, Nadlaou, SD, Toure, A, Sani, IM, Diallo, A, Kolie, C, Duraffour, S, Ifono, K, Maomou, A, Dore, K, Djidonou, HA, Bagayoko, A, Damey, PP, Camara, MN, Diallo, FB, Oumar, FT, Toure, K, Diaby, ML, Tipton, T, Carroll, MW

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebol... by Henao-Restrepo, A, Camacho, A, Longini, I, Watson, C, Edmunds, W, Egger, M, Carroll, M, Dean, N, Diatta, I, Doumbia, M, Draguez, B, Duraffour, S, Enwere, G, Grais, R, Gunther, S, Gsell, P, Hossmann, S, Watle, S, Kondé, M, Kéïta, S, Kone, S, Kuisma, E, Levine, M, Mandal, S, Mauget, T, Norheim, G, Riveros, X, Soumah, A, Trelle, S, Vicari, A, Røttingen, J, Kieny, M

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies by Bergeri, I, Whelan, MG, Ware, H, Subissi, L, Nardone, A, Lewis, HC, Li, Z, Ma, X, Valenciano, M, Cheng, B, Al Ariqi, L, Rashidian, A, Okeibunor, J, Azim, T, Wijesinghe, P, Le, L-V, Vaughan, A, Pebody, R, Vicari, A, Yan, T, Yanes-Lane, M, Cao, C, Clifton, DA, Cheng, MP, Papenburg, J, Buckeridge, D, Bobrovitz, N, Arora, RK, Van Kerkhove, MD